← Back to Search

Procedure

Participants scheduled for non-gynecologic abdominopelvic surgery for Surgery

N/A
Recruiting
Led By Kara Long Roche, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights

Study Summary

"This trial aims to determine how many people would consider a preventive surgery after watching an educational video. Participants will fill out questionnaires before and after watching the video at the clinic."

Who is the study for?
This trial is for women or individuals assigned female at birth, aged 45 or older, who have at least one fallopian tube and no plans for future children. They should be at average risk for ovarian cancer and scheduled for non-gynecologic abdominal/pelvic surgery. Candidates must understand English, not carry genes linked to ovarian cancer, nor have a history of gynecologic malignancies.Check my eligibility
What is being tested?
The study tests if participants are interested in an optional surgical procedure (salpingectomy) to prevent ovarian cancer after watching an educational video. It involves completing questionnaires before and after the video during a clinic visit.See study design
What are the potential side effects?
Since this trial focuses on gauging interest rather than performing the actual surgeries, there are no direct side effects from interventions being studied within this specific phase of research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Opportunistic Salpingectomy/OS after completion of educational module

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants scheduled for non-gynecologic abdominopelvic surgeryExperimental Treatment2 Interventions
Participants will be aged ≥45 years, have at least 1 fallopian tube, will not desire or plan to have children in the future, and will be scheduled to undergo non-gynecologic abdominopelvic surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Module
2016
N/A
~670
Salpingectomy
2011
Completed Phase 2
~670

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,936 Previous Clinical Trials
588,498 Total Patients Enrolled
3 Trials studying Surgery
6,585 Patients Enrolled for Surgery
Kara Long Roche, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently open for enrollment?

"Yes, the details on clinicaltrials.gov suggest that this investigation is presently in search of volunteers. Initially listed on 3/8/2024 and most recently revised on the same date, this research endeavor aims to recruit 400 participants distributed among 10 different locations."

Answered by AI

Are there numerous medical facilities conducting this research within the city?

"This clinical trial is being conducted at Memorial Sloan Kettering Nassau in Uniondale, Maryland for limited protocol activities, Johns Hopkins University in Baltimore, Massachusetts and Dana Farber Cancer Institute in Boston, New jersey for data collection purposes. Additionally, the study will also be carried out at 10 other sites."

Answered by AI

What is the upper threshold for the number of individuals enrolled in this medical study?

"Indeed, information from clinicaltrials.gov reveals that this current research study is actively seeking participants. Originally published on March 8th, 2024, the trial was last revised on the same day. The project aims to enroll a total of 400 individuals distributed among 10 various sites."

Answered by AI
~267 spots leftby Mar 2028